洋葱伯克霍尔德复合体研究新进展

摘要/Abstract

摘要： 洋葱伯克霍尔德复合体(Burkholderia cepacia complex, Bcc)是一组革兰阴性非发酵菌,是一种重要的条件致病菌,在肺囊性纤维化(CF)和慢性肉芽肿(CG)患者中特别容易引起感染,使患者出现无症状带菌、慢性感染或洋葱综合症。随着抗生素的大量使用,洋葱伯克霍尔德复合体引起上述两种疾病以外感染的报道逐渐增多,可引起肺炎、败血症、伤口感染、深部脓肿、尿路感染等。本文就洋葱伯克霍尔德复合体的基因型,流行病学特征、鉴定方法、毒力因子、耐药机制等方面的研究新进展进行了综述。

关键词: 洋葱伯克霍尔德复合体, 基因型, 流行病学特征, 鉴定方法, 毒力因子, 耐药机制

Abstract: The Burkholderia cepacia complex(Bcc) is a group of nonfermenter aerobic gram-negative bactetia also an important opportunistic pathogens which easily causes infections in cystic fibrosis patients and chronic granulomatous disease. All of this result in patients asymptomatic carriage, chronic infection or cepacia syndrome. Besides CF and CG, cases infected of Burkholderia cepacia complex are growing because antimicrobial agents abuse, it induces pneumonia, blood poisoning, wound infected, deeping abscess and urinary tract infections. The advances in the study of the Burkholderia cepacia complex in genomovars, epidemiology characteristic identification approach,virulent factor and resistant mechanism are reviewed in this paper.

Key words: Burkholderia cepacia complex , Genomovars, Epidemiology characteristic, Identification approach, Virulent factor, Resistant mechanism

中图分类号:

R446.1

王玉萍, 李小宁, 张莺莺. 洋葱伯克霍尔德复合体研究新进展[J]. 中国临床药理学与治疗学, 2014, 19(1): 101-104.

WANG Yu-ping, LI Xiao-ning, ZHANG Ying-ying. Advances in the study of Burkholderia cepacia complex[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(1): 101-104.

参考文献

[1] 雷金娥,袁莉,李和平,等.2006-2008年医院感染病原菌分布及耐药性分析[J].中华医院感染学杂志,2010,20(4):559-561.
[2] Mahenthiralingam E, Baldwin A, Dowson CG. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology[J]. J Appl Microbiol, 2008,104(6):1539-1551.
[3] Medina-Pascual MJ, Valdezate S, Villalón P,et al. Identification,molecular characterization and antimicrobial susceptibility of genomovars of the Burkholderia ceparia complex in Spain[J]. Eur J Clin Microbiol Infect Dis, 2012,31(12):3385-3396.
[4] Lynch KH, Stothard P, Dennis JJ. Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia specific bacteriophages[J].BMC Genomics,2012,13:223.
[5] Payne GW, Vandamme P, Morgan SH, et al. Development of a recA gene-based identification approach for the entire Burkholderia genus[J]. Appl Environ Microbiol, 2005,71(7):3917-3927.
[6] Baldwin A, Mahenthiralingam E, Thickett KM,et al. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex[J]. J Clin Microbiol, 2005, 43(9):4665-4673.
[7] Baldwin A, Mahenthiralingam E, Drevinek P,et al. Environmental Burkholderia cepacia complex isolates in human infections[J]. Emerg Infect Dis, 2007,13(3):458-461.
[8] Mahenthiralingam E, Baldwin A, Drevinek P,et al. Multilocus sequence typing breathes life into a microbial metagenome[J]. PLoS One, 2006, 20:117.
[9] Dalmastri C, Baldwin A, Tabacchioni S,et al. Investigating Burkholderia cepacia complex populations recovered from Italian maize rhizosphere by multilocus sequence typing[J]. Environ Microbiol, 2007,9(7):1632-1639.
[10] Brown AR,Govan JR. Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples[J]. J Clin Microbiol,2007,45(6):1920-1926.
[11] Plesa M, Kholti A, Vermis K,et al. Conservation of the opcL gene encoding the peptidoglycan-associated outermembrane lipoprotein among representatives of the Burkholderia cepacia complex[J]. J Med Microbiol,2004,53(5):389-398.
[12] Masoud H, Perry MB, Brisson JR,et al. Structural elucidation of the novel core oligosaccharide from LPS of Burkholderia cepacia serogroup O4[J]. Glycobiology, 2009,19(5):462-471.
[13] Soyza AD, Silipo A, Lanzetta R,et al. Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides[J].Innate immunity,2008,14(3):127-144.
[14] Saldías MS, Ortega X, Valvano MA. Burkholderia cenocepacia O antigen lipopolysaccharide prevents phagocytosis by macrophages and adhesion to epithelial cells[J]. J Med Microbiol, 2009,58(12):1542-1548.
[15] Ibrahim M, Tang Q, Shi Y, et al. Diversity of potential pathogenicity and biofilm formation among Burkholderia cepacia complex water,clinicai,and agricultural isolates in China[J]. World J Microbiol Biotechnol,2012,28(5):2113-2123.
[16] Sajjan US, Hershenson MB, Forstner JF,et al. Burkholderia enocepacia ET12 strain activates TNFR1 signalling in cystic fibrosis airway epithelial cells[J]. Cell Microbiol, 2008,10(1):188-201.
[17] Sass A, Marchbank A, Tullis E, et al.Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis[J].BMC Genomics,2011,12:373.
[18] 陶兴和,朱以军.下呼吸道感染中非发酵菌的分布及耐药分析[J].中华医院感染学杂志,2010,20(2):275-277.
[19] 李桂秋,路娟,赵金英,等.重症监护病房非发酵菌分布及耐药性分析[J].中国微生态学杂志,2010,22(8):708-713.
[20] 朱光明,从宏亮.临床分离的洋葱伯克霍尔德菌的耐药性分析[J].现代中西医结合杂志,2010,19(3):1645-1646.
[21] Guglierame P, Pasca MR, De Rossi E,et al. Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome[J]. BMC Microbiol, 2006:6:66.
[22] Poirel L, Rodriguez-Martinez JM, Plésiat P,et al. Naturally occurring class a β-Lactamases from the Burkholderia cepacia complex[J]. Antimicrob Agents Chemother,2009,53(3):876-882.
[23] Kooi C, Sokol PA. Burkholderia cenocepacia zinc metalloproteases influence resistance to antimicrobial peptides[J]. Microbiology, 2009,155(9):2818-2825.
[24] Loutet SA, Di Lorenzo F, Clarke C,et al. Transcriptional responses of Burkholderia cenocepacia to polymyxin B in isogenic strains with diverse polymyxin B resistance phenotypes[J].BMC Genomics,2011,12:472.